GenMark Diagnostics To Present At The 35th Annual Canaccord Genuity Growth Conference

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced today that Hany Massarany, President and Chief Executive Officer, will present at the 35th Annual Canaccord Genuity Growth Conference to be held in Boston, Massachusetts at the InterContinental Hotel on Thursday, August 13, 2015 at 8:30 a.m. Eastern Time. The presentation will be made available at http://ir.genmarkdx.com.

ABOUT GENMARK DIAGNOSTICS

GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of automated, multiplex molecular diagnostic testing systems that detect and measure DNA and RNA targets to diagnose disease and optimize patient treatment. Utilizing GenMark’s proprietary eSensor^® detection technology, GenMark’s eSensor XT-8^TM system is designed to support a broad range of molecular diagnostic tests with a compact, easy-to-use workstation and self-contained, disposable test cartridges. The eSensor detection technology is also incorporated into GenMark’s sample-to-answer system, ePlex^TM. For more information, visit www.genmarkdx.com.